POST Online Media Lite Edition



 

Topic: MERCK

111 results were found.

Commission fines Sigma-Aldrich €7.5 million for providing misleading information during Merck takeover investigation - May 10, 2021

Whistleblower: FDA didn't react to blood, urine and feces in Merck facility - April 3, 2021

Merck: Organon will acquire Alydia Health - March 31, 2021

Merck appoints Frank Clyburn to lead Human Health - March 17, 2021

Merck KGaA FY20 profit up - March 5, 2021

Merck to the rescue of Johnson & Johnson COVID-19 vaccine - March 3, 2021

Merck buys Poultry Sense, monitoring solutions company from UK - March 1, 2021

Merck to buy Pandion Therapeutics in $1.85 billion deal - February 25, 2021

4D Pharma, Merck and Pfizer ink trial collaboration for carcinoma drug - February 8, 2021

Kenneth C. Frazier to retire as Merck CEO - February 5, 2021

Merck discontinues development of COVID-19 vaccine candidates - January 25, 2021

Merck signs $356 million U.S. supply deal for its experimental coronavirus treatment - December 23, 2020

Merck to acquire VelosBio - November 6, 2020

Merck to acquire Themis - May 27, 2020

Merck net sales increased - May 14, 2020

Merck net sales rose 8.9% - March 5, 2020

Merck Q4 sales increased 8 percent, plans to spin off women businesses - February 5, 2020

Merck establishes $2.5 billion strategic oncology collaboration with Taiho and Astex - January 7, 2020

Merck expands in Wilson County, N.C., will invest $57 million, employ 55 - December 6, 2019

Merck KGaA Q3 net profit edges up - November 14, 2019

Merck Q3 pharmaceutical sales $11.1 billion - October 29, 2019

Merck completes 5.8 billion euros acquisition of Versum Materials - October 7, 2019

U.S. Department of Health giving $23 million to Merck to make Ebola vaccine - August 22, 2019

Merck Q2 net income soared 90.8% - August 8, 2019

Merck's global sales jump 12% in Q2 - July 30, 2019

Merck to buy Tilos Therapeutics for up to $773 million - June 10, 2019

Merck to acquire Peloton Therapeutics for $1.05 billion - May 21, 2019

Merck KgaA Q1 profit declines - May 14, 2019

Merck to invest $1 billion in Rockingham County, Va. - May 7, 2019

Merck Q1 sales $10.8 billion - April 30, 2019

Merck KGaA agrees $6.5 billion takeover of Versum Materials - April 12, 2019

Merck KGaA gets Versum's support for sweetened $6.5 billion offer - April 8, 2019

Merck goes hostile with $5.9 billion takeover offer for Versum - March 26, 2019

Merck KGaA net income grew 29.5 percent - March 7, 2019

Merck KGaA to Versum: Your own financial advisor supports our takeover bid - March 6, 2019

Versum Materials rejects Merck KGaA's 5.9 billion offer - March 2, 2019

GlaxoSmithKline and Merck KGaA strike deal worth up to $4 billion - February 6, 2019

Merck Q3 net income $1.83 billion - February 2, 2019

Merck to acquire Antelliq Group for EUR2.1 billion plus debt - December 14, 2018

Merck Q3 sales rose 6.6% - November 14, 2018

EU OK with $3.9 billion P&G deal for Merck's consumer health business - August 28, 2018

Merck KGaA Q2 net income down 42% - August 10, 2018

Merck Q2 non-GAAP EPS $1.06 - July 28, 2018

Merck KGaA Q1 profit after tax down 34.8 percent - May 15, 2018

Procter & Gamble to acquire Merck unit in $4.2 billion deal - April 19, 2018

Merck KgaA FY17 net profit climbs, EBITDA down - March 8, 2018

Merck to buy Viralytics for $394 million - February 21, 2018

Merck posts advance in Q4 profit - February 2, 2018

Merck slips to loss in Q3 - October 27, 2017

Merck considers sale of consumer health business - September 5, 2017

Merck KgaA Q2 profit climbs - August 3, 2017

Merck Q2 worldwide sales $9.9 billion - July 28, 2017

AstraZeneca, Merck in collaboration on cancer drug, will receive up to $8.5 billion - July 27, 2017

EU charges Merck KGaA, GE, Canon, companies risk hefty fines - July 6, 2017

Merck Q1 profit dips, adjusted EBITDA rises - May 18, 2017

Merck Q1 Non-GAAP EPS $0.88 - May 2, 2017

Merck Q4 net income climbed 113.8 percent - March 9, 2017

Merck to take $2.9bn pre-tax impairment charge on HCV drug - February 24, 2017

Merck posts 21 percent increase in Q4 profit - February 2, 2017

Eli Lilly & Co. expands immuno-oncology collaboration with Merck - January 11, 2017

Merck EBITDA pre exceptionals rose sharply by 24.3% - November 15, 2016

Merck & Co posts 10% increase in Q3 profit - October 25, 2016

Sanofi files U.S. suit against Merck over patents - September 19, 2016

Merck & Co Q2 profit climbed 75 percent - July 29, 2016

Merck to acquire Afferent Pharmaceuticals in $1.25 billion deal - June 11, 2016

Thanks to Sigma-Aldrich, Merck increases sales, earnings - May 19, 2016

Merck to invest $168 million in Rockingham County, Va. - March 29, 2016

Gilead Sciences to pay Merck $200 million for infringing two patents - March 25, 2016

Merck pays $20 million for new cancer drug from Harvard - March 22, 2016

Sanat Chattopadhyay named president of Merck manufacturing division - March 9, 2016

Sanofi Pasteur and Merck end their joint work on vaccines - March 8, 2016

Merck Q4 worldwide sales down 3% to $10.2 billion - February 3, 2016

Merck solves Vioxx class action, will pay $830 million - January 15, 2016

Sigma-Aldrich and Merck KGaA have EU approval for acquisition - November 11, 2015

Merck Q3 worldwide sales $10.1 billion, 5% down - October 27, 2015

Stefan Oschmann appointed new executive board chairman of Merck - October 14, 2015

ANI Pharmaceuticals to buy two products from Merck for $75+ million - September 22, 2015

Sigma-Aldrich good to be bought by Merck KGaA - August 11, 2015

Merck Ebola vaccine candidate has 100 percent efficacy - August 1, 2015

Merck Q2 non-GAAP EPS was $0.86, GAAP EPS was $0.24 - July 29, 2015

Allergan buys rights to Merck's migraine drugs - July 8, 2015

Acquisition of Sigma-Aldrich by Merck KGaA good to go - June 17, 2015

Merck Q1 worldwide sales $9.4 billion, down 8 percent - April 29, 2015

Merck buys Swiss-based OncoEthix for $110m plus up to $265 million - December 22, 2014

Merck names EVP, global public policy and population health - December 11, 2014

Merck to buy Cubist Pharmaceuticals for $8.4 billion - December 8, 2014

Merck does not want to sell $1 billion consumer health business - November 28, 2014

Merck and NewLink Genetics together against Ebola - November 25, 2014

Merck Q3 non-GAAP EPS $0.90 - October 28, 2014

Sigma-Aldrich to be acquired by Merck - September 23, 2014

Merck Q2 sales $10.9 billion - July 30, 2014

Merck to buy Idenix Pharmaceuticals - June 9, 2014

Merck Q1 2014 GAAP EPS $0.57 - May 15, 2014

Merck sells ophthalmology products to Santen Pharmaceutical Co. - May 14, 2014

Bayer to buy Merck's consumer care business for $14.2bn - May 6, 2014

Merck extends offer for AZ Electronic Materials to May 2 - April 19, 2014

Robert M. Davis to succeed Peter N. Kellogg as Merck CFO - March 31, 2014

Merck sales $11.3 billion in Q4 - February 5, 2014

Ablynx and Merck in agreement worth up to 1.7 billion euros - February 3, 2014

Merck offers 1.9 billion euros for AZ Electronic Materials - December 6, 2013

Merck appoints CIO - September 2, 2013

Merck Serono joins forces with Quintiles - May 20, 2013

Merck and Pfizer together against type 2 diabetes - April 30, 2013

Roger M. Perlmutter president of Merck Research Laboratories - March 8, 2013

Merck KGaA: Elmar Schnee leaves, Stefan Oschmann successor - December 13, 2010

Merck elects Kenneth C. Frazier as next CEO - December 1, 2010

Merck: Kenneth C. Frazier new chief executive officer - November 30, 2010

Merck announces senior management appointments - April 29, 2010

Merck: Bridgette P. Heller new EVP and president - February 16, 2010

Merck: Michael Rosenblatt EVP, chief medical officer - December 16, 2009

Three directors for newly-combined Merck - September 4, 2009


Back home